Abyrx
1 Bridge Street
Suite 121
Irvington
New York
10533
United States
Tel: 914-357-2600
Fax: 914-231-7884
Website: http://www.abyrx.com/
Email: info@abyrx.com
7 articles about Abyrx
-
Abyrx Receives FDA Clearance for MONTAGE® Settable Bone Putty for Use in Cardiothoracic Surgery
9/26/2023
Abyrx, Inc. today announced that the United States Food and Drug Administration (FDA) has provided regulatory clearance for the company's MONTAGE® Settable Bone Putty for use in cardiothoracic surgery following sternotomy.
-
Abyrx Receives Additional FDA Clearances for MONTAGE® Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
4/5/2023
Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for use during surgical procedures, today announced its receipt of additional United States Food and Drug Administration (FDA) clearances for the company's MONTAGE® Settable, Resorbable Bone Putty as both a bone void filler and cranial bone cement
-
Abyrx® Appoints Gary D. Cohn as Director
11/14/2018
Former Director of the U.S. National Economic Council and Goldman Sachs COO joins biomaterial sciences company Board of Directors
-
Abyrx Announces Expansion Of Exclusive, Worldwide License Agreement With Bezwada Biomedical; Completes $10M Equity Financing.
12/6/2016
-
Abyrx Announces National Distribution Partnership With Unify Surgical To Support Growing Demand For Abyrx's Biosurgical Products In The United States' Cardiothoracic Surgery Marketplace
6/17/2014
-
Abyrx Announces Option To Acquire Haibo Biotechnology Institute's Soft Tissue Hemostat Technology Platform
1/28/2014
-
Abyrx Receives FDA 510(k) Clearance for New Resorbable Hemostatic Bone Putty (Hemasorb Plus)
9/4/2013